Use of analogues of methionine and methionyl adenylate to sample conformational changes during catalysis in Escherichia coli methionyl-tRNA synthetase. 2003

Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
Laboratoire de Biochimie, Unité Mixte de Recherche no 7654, CNRS-Ecole Polytechnique, F-91128 Palaiseau cedex, France.

Binding of methionine to methionyl-tRNA synthetase (MetRS) is known to promote conformational changes within the active site. However, the contribution of these rearrangements to enzyme catalysis is not fully understood. In this study, several methionine and methionyl adenylate analogues were diffused into crystals of the monomeric form of Escherichia coli methionyl-tRNA synthetase. The structures of the corresponding complexes were solved at resolutions below 1.9A and compared to those of the enzyme free or complexed with methionine. Residues Y15 and W253 play key roles in the strength of the binding of the amino acid and of its analogues. Indeed, full motions of these residues are required to recover the maximum in free energy of binding. Residue Y15 also controls the size of the hydrophobic pocket where the amino acid side-chain interacts. H301 appears to participate to the specific recognition of the sulphur atom of methionine. Complexes with methionyl adenylate analogues illustrate the shielding by MetRS of the region joining the methionine and adenosine moieties. Finally, the structure of MetRS complexed to a methionine analogue mimicking the tetrahedral carbon of the transition state in the aminoacylation reaction was solved. On the basis of this model, we propose that, in response to the binding of the 3'-end of tRNA, Y15 moves again in order to deshield the anhydride bond in the natural adenylate.

UI MeSH Term Description Entries
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D008718 Methionine-tRNA Ligase An enzyme that activates methionine with its specific transfer RNA. EC 6.1.1.10. Methionyl T RNA Synthetase,Met-tRNA Ligase,Methionyl-tRNA Synthetase,Ligase, Met-tRNA,Ligase, Methionine-tRNA,Met tRNA Ligase,Methionine tRNA Ligase,Methionyl tRNA Synthetase,Synthetase, Methionyl-tRNA
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000249 Adenosine Monophosphate Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. AMP,Adenylic Acid,2'-AMP,2'-Adenosine Monophosphate,2'-Adenylic Acid,5'-Adenylic Acid,Adenosine 2'-Phosphate,Adenosine 3'-Phosphate,Adenosine 5'-Phosphate,Adenosine Phosphate Dipotassium,Adenosine Phosphate Disodium,Phosphaden,2' Adenosine Monophosphate,2' Adenylic Acid,5' Adenylic Acid,5'-Phosphate, Adenosine,Acid, 2'-Adenylic,Acid, 5'-Adenylic,Adenosine 2' Phosphate,Adenosine 3' Phosphate,Adenosine 5' Phosphate,Dipotassium, Adenosine Phosphate,Disodium, Adenosine Phosphate,Monophosphate, 2'-Adenosine,Phosphate Dipotassium, Adenosine,Phosphate Disodium, Adenosine
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
October 1991, Biochemistry,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
May 1999, Bioorganic & medicinal chemistry letters,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
September 1981, The Journal of biological chemistry,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
December 1998, Bioorganic & medicinal chemistry letters,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
February 2020, Journal of structural biology,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
August 1976, Biochemistry,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
August 1987, Biochemistry,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
January 1975, Biochemical Society transactions,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
September 1994, Journal of molecular biology,
Thibaut Crepin, and Emmanuelle Schmitt, and Yves Mechulam, and Peter B Sampson, and Mark D Vaughan, and John F Honek, and Sylvain Blanquet
November 1991, FEBS letters,
Copied contents to your clipboard!